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monltodng. Ventdcular ate during persistent AF was not significantly reduced 
with digitalis adjunct and was comparable in the 4 groups (pts lying in bed). 
Condusion: PRFat 600 mg unique oral dose Is safe and of p ro~ efficacy 
in restoring SR in pts with recent onset AR Digitalis does not add any useful 
effect in term of safety and of ventricular ate control in these hospitalized 
pts. PRForal loading dose Is a valide altematwe to the Lv. Infusion in order 
to convert AF te SR. 
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~ OMerent Pharmacologic Converting Treatment Ior  
Recant-Onset Aldal Rbdl lst ion:  Evaluation on 377 
Pstlents 
Giuseppe Bodani. Alessandro Capu¢cl, Glen Luca Bofto, Ida Rub(no. 
Tizieno Lenzi. Maudzio Onged, Maure Biffi. Paolo Sabbatani. 
Mafio Sartgulneftl, Bruno Magnant. Institute of Cardiovascular Diseases, 
~',ivers~y ofBologna. and Atrial Rbr i l t~  Study Group Italy 
We examined on a patient papuistion of 377 patients (pts.) the efficacy 
and safety of different therapeutic stategies for converting recent-onset atrial 
fibrillation (AF) (_< 7 days duration) to sinus d'~thm (SR). All the pts were 
in NYHA class __. 2, without s~cs or symptoms of heart failure and were 
hcsp'~lised. The pts were randomly allocated to treatment with one of the 
following drugs: Lv.amiodarone (i.v. AM) (5 mg/Kg as bolus, then 1.8 gr/24 
hours) (30 pts), Lv.prol~fenone (i,v, PF') (2 mg/Kg as bolus, then 0.0078 
m~min)  (38 pts), oral loading with prepafenene (oral PF) (600 mg p.o. as 
single dose) (119 pts) and oral loading with flecainido (oral FL) (3Q0 mg p.o. 
as single dose) (69 tots). All the pts were submitted to He(tar moniiodng and 
conversions Io SR were evaluated at 1, 3 and 8 hours. 
Results PLA Lv. AM i.v. PF Oral PF Oral FL 
(11 = 121) (n = 30) In - 38) (n = "119) (n = 69) 
SR < 1 hrs 11 (9%) 2 (7%) 13 (34%) 10 (8%) 9 (13%) 
SR < 3 llrs 22 (18%) 7 (23%) 19 (50%)* 54 (45%)* 39 (56,5%)* 
SR < 8 hrs 45 (37%) 13 {43%) 26 (68%)" 91 (78%)" 52 (75%)* 
Adv. Eft. 0 2 1 4 
*p < 0.01 vs PLA, Adv. Eft. = advePt~e effects 
In conclusion : 1) i.v. AM is not effective at short term in this kind of patient 
population; 2) i.v. PF achieves an higher efficacy within I hour compared to 
oral loading schedules (either with PF or FL) but without different efficacies at 
3 and 8 hours; 3) the overall results undertirm how oral loading with PF or FL 
is a valid alternative to ¢onventi0nals protocols in hospital(sad I~tisnts; 4) the 
evaluation of placebo effect is mandatory for the study of recent-onset AR 
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~ Competit ive Binding Between Cocaine and 
Udoce ine  
Robert J. Hadman, Dong Liu, Henry S. Loeb, Thomas L, McKiemen, Patdck 
J, Scenlon, Jerry L Bauman. Hines VA Hospital and Loyola University 
Medical Center, Maywcod, IL 
Lidoceine (L), a Na channel Mocker with fast binding kinetics, may compete 
for the same reeapter with cocaine (C), a Na channel Mocker with slew 
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binding kinetics. To see If L can reverse C-induced depression of dVIdtmm 
of phase 0 of the action potential, we studied 16 guinea pig papillary muscle 
preparations timulated at 1 Hz dudng control, dudng exposure to different 
concentrations of C, and dudng exposure of C and a fixed L cormentratlon 
(30 #M), The concentration-inhibition curve (Fig.) shows that addition of L 
shifted ECso of C from 77 uM tO 131.8 #M whereas Ernax remained the same 
(86.1% for C alone and 87.4% for C + L). 
These findings suggest that L Is able to displace C from its binding Sites 
due to L's faster binding kinetics. L may prove to be an antidote of C toxicity 
by reversing C slowing of ventdcular conduction. 
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~'~5-~ Estrogen Replacement Therapy Normalizes the 
Autonomic Control  o f  the Cardiovascular System In 
Menopausal Women 
Gtusappe M.C. Rosario, Filtppo Leonardo, Piotr Ponlkowsld, Fabio De Luea, 
Peter Collins. National Heart & Lung Institute, London, United Kingdom; 
University Of Rome, and Reggio Calabria Italy 
The menopause is associated with vasomotor instability and signs of in- 
creased sympathetic activity. The aim of the present study was to evaluate 
the effect of estrogen replacement herapy upon the autonomic control of 
the cardiovascular system in 18 menopausal healthy women, The subjects 
undanNent 24 hour ambulatory eleclrecardlographic monitoring before and 
after 1 and 4 months of therapy with estradiol 17/3 (1 mg orally). The au- 
tonomio control of the cardiovascular system was investigated by the study 
of heart rate variability, Mean heart rate was similar at baseline and after 1 
month but was lower at 4 months, A trend toward higher values of heart rate 
variability parameters was obsewed at 1 month but the changes were more 
evident after 4 months of therapy. 
Baseline (n = 18) 1 month (n = 17) 4 months (n - 18) 
mRR (ms) 714 ± 47 725 4. 53 876 4. 27* 
sdRR (ms) 117 4.13 123 =E 12 139 :E 15" 
rMSSD (me) 24.5±3 324.8" 33.14.8" 
pNNS0 (%) 4:1:2 4.64.5 9.8:1:7=" 
HF (ms 2) 92 4. 31 156 4. 49* 225 4. 69** 
LF (ms 2) 325 d: 123*" 465 4. 229* 695 4. 425** 
*p < 0.05, **p < 0.01 conl;~red to baseline 
In conclusion estrogen replacement herapy normalizes the autonomic con- 
trol of the cardiovascular system in healthy menopausal women, The affect of 
estrogen therapy although present after I month of therapy becomes evident 
after 4 months. 
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~ Malignant Neurocard iogenic  Syncope: Eff icacy and 
Sa..fety of  ~-Block ing Treatment Guided by Head Up 
. I t  Test 
Gtuseppo Boriani, Mauro Bifli, Peele Sabbatani, Lorenzo Frapatti, 
Gabrtele Bronzer'd, B. MagnanL Institute of Cardiovascular Diseases, 
Univem~ of Bo~n~ Italy 
Thirty patients, mean age 32 ± 13 years (range 11-7~), with recurrent 
syncopat and nsar-syncepal episodes of unexplained origin in the previous 
year (range 2-12, average 6 :E 2) underwent head up tilt test (HUT) lot 
diagnostic purposes. Following 10 minutes rest in recumbent position, HUT 
was performed at at 70 ~ for 25 minutes; if indicated, tsoproterenol testing 
was performed at incremental dosages. All patients expedenced syncope 
dildng HUT (15 during isoproterenol infusion, range 1-3 pg, average 1.6 
.g): 22 were of vesndapressor type, 5 of mixed, and 3 of cardiotnhlbltory 
type, ,8-blocking drugs were prescribed to all patients: 4 pmpranolol (240- 
320 mg in 3 divided doses), 26 metoproicl (100-150 mg twice doily), with 
a dose titration period of 5 to (6 days. HUT was repeated after 1 month: 
28 patients had a negative result, whereas 2 had respectively a persistent 
mixed and ~ vesodepressfve response. In 5 cases a first HUT on ~-blockers 
resulted t :.,e positive but after achievement of full dose HUT test resulted 
At an average follow up of 16 :E 4 months no patient had relapsing syncopal 
episodes; 4 patients (3 with vasodepressor and 1 with mixed type response) 
experienced llghthesdedness. No patient discontinued the drug due to long 
term treatment side effects. 
Clinical Events Previous Year Follow Up 
No. syncopal episodes 6 4. 2 0 p < 0.001 
NO. r~ar-sFcope (moan) 7 4. 0,4 0.3 4. 0.06 p < 0,001 
No. r~ear-syrcope (total) 159 6 p < 0,001 
In conclusion, p-blockers appear to be very effective and well follerated. An 
appropriate titration with of full beta-blockade seem necessary for achieve- 
merit of full efficacy. 
